Open AccessImplementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease
Author(s) -
Jena L Welch-Coltrane,
Anthony A Wachnik,
Meredith C.B. Adams,
Cherie R Avants,
Howard Blumstein,
Amber Brooks,
Andrew M. Farland,
Joshua B. Johnson,
Manoj Pariyadath,
Erik C Summers,
Robert W. Hurley
Publication year - 2021
Publication title -
pain medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 97
eISSN - 1526-4637
pISSN - 1526-2375
DOI - 10.1093/pm/pnab092
Subject(s) - medicine , hydromorphone , emergency medicine , disease , health care , regimen , cohort , physical therapy , retrospective cohort study , analgesic , disease management , intensive care medicine , anesthesia , receptor , opioid , parkinson's disease , economics , economic growth
Patients with sickle cell disease (SCD) face inconsistent effective analgesic management, leading to high inpatient healthcare utilization and significant financial burden for healthcare institutions. Current evidence does not provide guidance for inpatient management of acute pain in adults with sickle cell disease. We conducted a retrospective analysis of a longitudinal cohort quality improvement project to characterize the role of individualized care plans on improving patient care and reducing financial burden in high healthcare-utilizing patients with SCD-related pain.